John W. Hubbard

Insider Reports History

Entity
Individual
Location
101 Poor Farm Road 3 Rd Floor, Princeton, New Jersey
Signature
/s/ Christine Pellizzari, Attorney-in-fact for John W. Hubbard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John W. Hubbard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGILE THERAPEUTICS INC Director Common Stock 976 $830 $0.85 Jun 8, 2023 Direct
Science 37 Holdings, Inc. Former Director Common Stock 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Former Director Restricted Stock Units 0 $0 $5.75 Mar 12, 2024 Direct
AGILE THERAPEUTICS INC Director Employee Stock Option (Right to Buy) 1,065 Jun 8, 2023 Direct
Science 37 Holdings, Inc. Former Director Earn-Out Right 0 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Former Director Stock Option 0 Mar 12, 2024 Direct

Insider Reports Filed by John W. Hubbard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNCE Science 37 Holdings, Inc. Mar 12, 2024 5 -11,788 4 Mar 12, 2024 Former Director
AGRX AGILE THERAPEUTICS INC Jun 8, 2023 2 0 4 Jun 9, 2023 Director
SNCE Science 37 Holdings, Inc. May 11, 2023 3 0 4 May 12, 2023 Director
AGRX AGILE THERAPEUTICS INC Jun 9, 2022 2 0 4 Jun 10, 2022 Director
SNCE Science 37 Holdings, Inc. May 23, 2022 1 0 4 May 24, 2022 Director
SNCE Science 37 Holdings, Inc. Oct 6, 2021 2 0 4 Oct 12, 2021 Director
SNCE Science 37 Holdings, Inc. Oct 6, 2021 1 0 4 Oct 8, 2021 Director
SNCE Science 37 Holdings, Inc. Oct 6, 2021 0 0 3 Oct 8, 2021 Director
AGRX AGILE THERAPEUTICS INC Jun 8, 2021 2 0 4 Jun 10, 2021 Director